PT994704E - Utilizacao de analogos do gaba tal como a gabapentina no fabrico de um medicamento para o tratamento de doencas inflamatorias - Google Patents

Utilizacao de analogos do gaba tal como a gabapentina no fabrico de um medicamento para o tratamento de doencas inflamatorias

Info

Publication number
PT994704E
PT994704E PT98934170T PT98934170T PT994704E PT 994704 E PT994704 E PT 994704E PT 98934170 T PT98934170 T PT 98934170T PT 98934170 T PT98934170 T PT 98934170T PT 994704 E PT994704 E PT 994704E
Authority
PT
Portugal
Prior art keywords
inflammatory diseases
gabapentine
manufacture
treatment
medicinal product
Prior art date
Application number
PT98934170T
Other languages
English (en)
Inventor
Charles Price Taylor Jr
Denis Schrier
Westlund-High Karin Nanette
Original Assignee
Univ Texas
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26728613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT994704(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Texas, Warner Lambert Co filed Critical Univ Texas
Publication of PT994704E publication Critical patent/PT994704E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT98934170T 1997-06-25 1998-06-24 Utilizacao de analogos do gaba tal como a gabapentina no fabrico de um medicamento para o tratamento de doencas inflamatorias PT994704E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5073697P 1997-06-25 1997-06-25
US8418398P 1998-05-04 1998-05-04

Publications (1)

Publication Number Publication Date
PT994704E true PT994704E (pt) 2005-08-31

Family

ID=26728613

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98934170T PT994704E (pt) 1997-06-25 1998-06-24 Utilizacao de analogos do gaba tal como a gabapentina no fabrico de um medicamento para o tratamento de doencas inflamatorias

Country Status (20)

Country Link
EP (1) EP0994704B1 (pt)
JP (2) JP3884486B2 (pt)
KR (1) KR100554319B1 (pt)
AT (1) ATE297722T1 (pt)
AU (1) AU735675B2 (pt)
CA (1) CA2294607C (pt)
CO (1) CO4940456A1 (pt)
DE (1) DE69830586T2 (pt)
DK (1) DK0994704T3 (pt)
ES (1) ES2244070T3 (pt)
HR (1) HRP980342A2 (pt)
HU (1) HU228454B1 (pt)
IL (2) IL132709A0 (pt)
IS (1) IS2279B (pt)
NO (1) NO329321B1 (pt)
NZ (1) NZ501626A (pt)
PL (1) PL191370B1 (pt)
PT (1) PT994704E (pt)
SI (1) SI0994704T1 (pt)
WO (1) WO1998058641A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100491282B1 (ko) 1996-07-24 2005-05-24 워너-램버트 캄파니 엘엘씨 통증 치료용 이소부틸가바 및 그의 유도체
DE69834204T2 (de) 1997-10-27 2007-03-29 Warner-Lambert Co. Llc Zyklische aminosäuren und deren derivate als arzneimittel
EP1047414A1 (en) * 1998-01-23 2000-11-02 Warner-Lambert Company Gabapentin and its derivatives for the treatment of muscular and skeletal pain
EP0974351A3 (en) * 1998-04-24 2000-12-13 Jouveinal Medicament for preventing and treating gastrointestinal damage
AU767119B2 (en) 1999-07-22 2003-10-30 University Of Rochester Method of treating symptoms of hormonal variation, including hot flashes
US6620829B2 (en) * 2000-10-17 2003-09-16 Warner-Lambert Company Method of treating noninflammatory cartilage damage
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
EP1543831A1 (en) * 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Pregabalin composition
WO2006008640A1 (en) * 2004-07-15 2006-01-26 Pharmacia & Upjohn Company Llc Non-aqueous suspension containing a drug having an unpleasant taste
WO2009087682A2 (en) * 2007-12-28 2009-07-16 Intas Pharmaceuticals Limited Stabilized injectable formulation of pregabalin
HU230031B1 (hu) 2010-03-01 2015-05-28 Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény
WO2011151708A1 (en) 2010-06-01 2011-12-08 Rubicon Research Private Limited Gastroretentive dosage forms of gaba analogs
WO2016032000A1 (ja) * 2014-08-29 2016-03-03 わかもと製薬株式会社 乳酸菌含有組成物
GB201617380D0 (en) 2016-10-13 2016-11-30 St George's Hospital Medical School Treatment for Osteoarthritis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
JPS6036413A (ja) * 1983-08-09 1985-02-25 Kaneshiro Nagai 炎症治癒促進剤
US6197819B1 (en) * 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
JPH0636413A (ja) * 1992-07-21 1994-02-10 Nakamichi Corp テ−プレコ−ダのテ−プガイド装置
KR100491282B1 (ko) * 1996-07-24 2005-05-24 워너-램버트 캄파니 엘엘씨 통증 치료용 이소부틸가바 및 그의 유도체
DE69737719D1 (de) * 1996-10-23 2007-06-21 Warner Lambert Co Substituierte gamma-aminobuttersäurederivate als arzneimittel

Also Published As

Publication number Publication date
JP3884486B2 (ja) 2007-02-21
CO4940456A1 (es) 2000-07-24
KR100554319B1 (ko) 2006-02-22
NO329321B1 (no) 2010-09-27
EP0994704A1 (en) 2000-04-26
DK0994704T3 (da) 2005-10-03
DE69830586D1 (de) 2005-07-21
NZ501626A (en) 2002-03-28
CA2294607A1 (en) 1998-12-30
SI0994704T1 (en) 2005-10-31
JP4452255B2 (ja) 2010-04-21
HUP0003730A3 (en) 2002-01-28
HRP980342A2 (en) 1999-02-28
HU228454B1 (en) 2013-03-28
IS2279B (is) 2007-09-15
DE69830586T2 (de) 2005-12-15
KR20010020509A (ko) 2001-03-15
ATE297722T1 (de) 2005-07-15
EP0994704B1 (en) 2005-06-15
IL132709A (en) 2006-10-05
ES2244070T3 (es) 2005-12-01
IS5239A (is) 1999-11-05
NO996468D0 (no) 1999-12-23
CA2294607C (en) 2007-09-25
JP2002506449A (ja) 2002-02-26
AU735675B2 (en) 2001-07-12
WO1998058641A1 (en) 1998-12-30
IL132709A0 (en) 2001-03-19
NO996468L (no) 2000-02-21
PL337847A1 (en) 2000-09-11
HUP0003730A1 (hu) 2001-04-28
AU8375898A (en) 1999-01-04
JP2006298929A (ja) 2006-11-02
PL191370B1 (pl) 2006-05-31

Similar Documents

Publication Publication Date Title
PT994704E (pt) Utilizacao de analogos do gaba tal como a gabapentina no fabrico de um medicamento para o tratamento de doencas inflamatorias
ATE461698T1 (de) Gaba-analoga zur verhütung und behandlung gastrointestinaler beschwerden
ES2176343T3 (es) Composiciones sanadoras de tratamiento de heridas causadas por el acne que contienen un piruvano, un antioxidante y una mezcla de acidos grasos.
CY1112310T1 (el) Προφαρμακα κομπρεταστατινης α1-φωσφορικης και κομπρεταστατινης β1-φωσφορικης
DE69434211D1 (de) Phenylacetate und derivate, allein oder in kombination mit anderen verbindungen, zur behandlung von neoplastischen und anderen erkrankungen
ATE321529T1 (de) Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
DK0696456T3 (da) Kombination af nekrosefremkaldende stoffer med stoffer, som aktiveres af nekroser, til selektiv behandling af tumorer og betændelsessygdomme
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
NZ333232A (en) Use of p-aminophenol derivatives (paracetamol) to treat neurodegenerative disease
ATE193651T1 (de) Therapeutisches system zur behandlung der psoriasis
PT1023034E (pt) Formulacoes cosmeticas para prevencao e tratamento da queda de cabelo
ES2125356T3 (es) Empleo de leflunomida para la inhibicion de interleuquina 8.
DE3480764D1 (de) Behandlung von anfaellen und hierfuer nuetzliche pharmazeutische zusammensetzungen.
DE69739482D1 (de) Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen
MX9305151A (es) Metodo para el tratamiento de enfermedades de la piel.
GT199900042A (es) Derivados biciclicos del acido hidroxamico.
AR031525A1 (es) Uso de una composicion que comprende un compuesto de modafinil para el tratamiento de la enfermedad de hiperactividad con déficit de atencion y la fatiga de esclerosis multiple, composiciones farmaceuticas, un envase terapeutico, metodo de identificacion de un compuesto que modula selectivamente la
RU2003117875A (ru) Фармацевтическая композиция для лечения воспалительных процессов заднего отрезка глаза "кселипос"
UA18225A (uk) Спосіб лікуваhhя раh
UA28771A (uk) Спосіб комбінованої лікарської профілактики гіпоксичного синдрому